AJCN EB Program 2010 Early Registration
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lenssen, P.
Right arrow Articles by Mattson, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lenssen, P.
Right arrow Articles by Mattson, D.
Agricola
Right arrow Articles by Lenssen, P.
Right arrow Articles by Mattson, D.

American Journal of Clinical Nutrition, Vol 67, 927-933, Copyright © 1998 by The American Society for Clinical Nutrition, Inc


ORIGINAL RESEARCH COMMUNICATIONS

Intravenous lipid dose and incidence of bacteremia and fungemia in patients undergoing bone marrow transplantation

P Lenssen, BA Bruemmer, RA Bowden, T Gooley, SN Aker and D Mattson
Department of Clinical Nutrition, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA. plenssen@fhcrc.org

Experimental data have implicated intravenous lipids as being immunosuppressive, yet evidence that lipids are associated with an increase in clinically documented infections is sparse. A prospective trial conducted in patients with hematologic malignancies who were undergoing bone marrow transplantation compared the incidence of bacteremia and fungemia during the first month after the transplant. Patients (n = 512) were randomly assigned to receive 6-8% (low dose) or 25-30% (standard dose) of total daily energy as a 20% lipid emulsion. An adaptive randomization scheme stratified for treatments that might influence infection outcome (hematopoietic growth factors, fluconazole, graft-versus-host disease prophylaxis with steroids, pentoxifylline, intravenous immunoglobulin, and total body irradiation). The transplant type (autologous, related family donor, or unrelated donor) did not differ in distribution between treatment groups. Of the evaluable patients (n = 482), 55 patients in the standard-dose lipid group developed bacteremia or fungemia compared with 54 in the low-dose lipid group. The log-rank test comparing the time to first infection found no association between the incidence of bacteremia or fungemia and intravenous lipid (P = 0.95). Similar results were found when analyzed as intent-to-treat (P = 0.98), when bacterial or fungal infections at all sites were included (P = 0.94), and when the observation period was extended to 60 d (P = 0.58 for blood infections, P = 0.77 for infections at all sites). These data indicate that moderate amounts of intravenous lipid rich in linoleic acid are not associated with an increased incidence of bacterial or fungal infections in patients undergoing bone marrow transplantation and receiving total parenteral nutrition.


This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
M. W Versleijen, W. J Oyen, H. M Roelofs, S. E van Emst-de Vries, P. H Willems, J. B Jansen, and G. J Wanten
Immune function and leukocyte sequestration under the influence of parenteral lipid emulsions in healthy humans: a placebo-controlled crossover study
Am. J. Clinical Nutrition, March 1, 2008; 87(3): 539 - 547.
[Abstract] [Full Text] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
X. Li, J. Ying, S. Zeng, Y. Li, H. Yang, L. Shen, J. Han, J. Chen, and H. Shen
The Effects of a Short-Term Long-Chain-Triglyceride Infusion on the Postoperative Immune Function of Pediatric Patients Receiving a Gastrointestinal Surgical Procedure
JPEN J Parenter Enteral Nutr, January 1, 2008; 32(1): 72 - 77.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
G. J. Wanten and P. C Calder
Immune modulation by parenteral lipid emulsions
Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1171 - 1184.
[Abstract] [Full Text] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
X. Li, J. Ying, S. Zeng, L. Shen, X. Wan, X. Li, H. Tan, H. Pei, J. Zhou, and H. Shen
A Short-Term Long-Chain Triglycerides Infusion Has No Influence on Immune Function of Adult Patients Undergoing Gastrointestinal Surgery
JPEN J Parenter Enteral Nutr, May 1, 2007; 31(3): 167 - 172.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
E. J. Ladas, N. Sacks, L. Meacham, D. Henry, L. Enriquez, G. Lowry, R. Hawkes, G. Dadd, and P. Rogers
A Multidisciplinary Review of Nutrition Considerations in the Pediatric Oncology Population: A Perspective From Children's Oncology Group
Nutr Clin Pract, August 1, 2005; 20(4): 377 - 393.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
G. J. Wanten, M. G. Netea, T. H. Naber, J. H. Curfs, L. E. Jacobs, T. J. Verver-Jansen, and B.-J. Kullberg
Parenteral Administration of Medium- but Not Long-Chain Lipid Emulsions May Increase the Risk for Infections by Candida albicans
Infect. Immun., November 1, 2002; 70(11): 6471 - 6474.
[Abstract] [Full Text] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
P. Lenssen, B. Bruemmer, S. N. Aker, and G. B. McDonald
Nutrient Support in Hematopoietic Cell Transplantation
JPEN J Parenter Enteral Nutr, July 1, 2001; 25(4): 219 - 228.
[Abstract] [PDF]


Home page
Nutr Clin PractHome page
T. W. Mattox
Specialized Nutrition Management of Patients Receiving Hematopoietic Stem Cell Transplantation
Nutr Clin Pract, February 1, 1999; 14(1): 5 - 15.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by The American Society for Nutrition